Publications by authors named "Susan Perrine"

Claim this Profile
T
The All One Community (A1C) Program Boosts Diabetes Outcomes in Under-Engaged Asian Immigrants Through Culturally Tailored Education and Partner-Supported Enrollment.
Alia Southworth, Susan M Perrine, Paula Lozano, Chieko Maene, Shivam Bhargava

J Health Care Poor Underserved· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Come together over me: Cells that form the dermatocranium and chondrocranium in mice.
M Kathleen Pitirri, Joan T Richtsmeier, Mizuho Kawasaki, Abigail P Coupe, Susan Motch Perrine

Anat Rec (Hoboken)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Universal conditional networks (UniCoN) for multi-age embryonic cartilage segmentation with sparsely annotated data.
Nishchal Sapkota, Yejia Zhang, Zihao Zhao, Maria Jose Gomez, Yuhan Hsi, Susan M Motch Perrine

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal conditional networks (UniCoN) for multi-age embryonic cartilage segmentation with Sparsely annotated data.
Nishchal Sapkota, Yejia Zhang, Zihao Zhao, Maria Jose Gomez, Yuhan Hsi, Susan M Motch Perrine

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects.
Louis H Junker, Biaoru Li, Xingguo Zhu, Sivanagireddy Koti, Ryan E Cerbone, Susan Perrine

Blood Cells Mol Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease.
Betty S Pace, Susan Perrine, Biaoru Li, Levi Makala, Hongyan Xu

Blood Cells Mol Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cartilage Segmentation in High-Resolution 3D Micro-CT Images via Uncertainty-Guided Self-training with Very Sparse Annotation.
Hao Zheng, Susan M Motch Perrine, M Kathleen Pitirri, Kazuhiko Kawasaki, Chaoli Wang

Med Image Comput Comput Assist Interv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An oral Hemokine, α-methylhydrocinnamate, enhances myeloid and neutrophil recovery following irradiation in vivo.
Douglas V Faller, Serguei A Castaneda, Daohong Zhou, Merriline Vedamony, Peter E Newburger, Susan P Perrine

Blood Cells Mol Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of hydroxyurea on F-cells in sickle cell disease and potential impact of a second fetal globin inducer.
Yan Dai, Jose Sangerman, Mehdi Nouraie, Aidan D Faller, Patricia Oneal, Susan Perrine

Am J Hematol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice.
Michael S Boosalis, Jose I Sangerman, Gary L White, Roman F Wolf, Ling Shen, Susan P Perrine

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic fetal-globin inducers reduce transcriptional repression in hemoglobinopathy erythroid progenitors through distinct mechanisms.
Yan Dai, Jose Sangerman, Hong Yuan Luo, Suthat Fucharoen, David H K Chui, Susan P Perrine

Blood Cells Mol Dis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted fetal hemoglobin induction for treatment of beta hemoglobinopathies.
Susan P Perrine, Betty S Pace, Douglas V Faller

Hematol Oncol Clin North Am· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 trial of HQK-1001 in HbE-β thalassemia demonstrates HbF induction and reduced anemia.
Poramin Patthamalai, Suthat Fuchareon, Nattawara Chaneiam, Richard G Ghalie, David H K Chui, Susan P Perrine

Blood· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of HQK-1001, an oral fetal haemoglobin inducer, in β-thalassaemia intermedia.
Adlette Inati, Mario Kahale, Susan P Perrine, David H K Chui, Ali T Taher

Br J Haematol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease.
Abdullah Kutlar, Marvin E Reid, Adlette Inati, Ali T Taher, Miguel R Abboud, Susan P Perrine

Am J Hematol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stressing HbF synthesis: role of translation?
Jane-Jane Chen, Susan Perrine

Blood· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemia.
Suthat Fucharoen, Adlette Inati, Noppadol Siritanaratku, Swee L Thein, William C Wargin, Susan P Perrine

Br J Haematol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease.
Abdullah Kutlar, Kenneth Ataga, Marvin Reid, Elliott P Vichinsky, Lynne Neumayr, Susan P Perrine

Am J Hematol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies.
Sajal K Ghosh, Susan P Perrine, Douglas V Faller

Adv Virol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Butyrate histone deacetylase inhibitors.
Kosta Steliou, Michael S Boosalis, Susan P Perrine, José Sangerman, Douglas V Faller

Biores Open Access· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents.
Sajal K Ghosh, Susan P Perrine, Robert M Williams, Douglas V Faller

Blood· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling.
Sibaji Sarkar, Ana L Abujamra, Jenny E Loew, Lora W Forman, Susan P Perrine

Anticancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo.
Michael S Boosalis, Serguei A Castaneda, Marie Trudel, Rodwell Mabaera, Gary L White, Susan P Perrine

Blood Cells Mol Dis· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching globin, raising red cells.
Susan P Perrine

Blood· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term toxicity study of ST-20 (NSC-741804) by oral gavage in Sprague-Dawley rats.
Pramod S Terse, Jerry D Johnson, Michael A Hawk, Glenn D Ritchie, Michael J Ryan, Susan P Perrine

Toxicol Pathol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis